Novo Nordisk A/S ADR buy TD Cowen
Start price
03.02.26
/
50%
€48.60
Target price
03.02.27
-
Performance (%)
-14.09%
Price
22:26
€41.75
Summary
This prediction is currently active. The price of Novo Nordisk A/S ADR has decreased since the start of the prediction. Compared to the start price this results in a performance of -14.09%. This prediction currently runs until 03.02.27. The prediction end date can be changed by TD_Cowen at any time. TD_Cowen has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Novo Nordisk A/S ADR | 1.091% |
| iShares Core DAX® | 0.193% |
| iShares Nasdaq 100 | -1.353% |
| iShares Nikkei 225® | -0.426% |
| iShares S&P 500 | -1.008% |
Comments by TD_Cowen for this prediction
In the thread Novo Nordisk A/S ADR diskutieren
Novo Nordisk A/S (NYSE:NVO) had its "buy" rating reaffirmed by analysts at TD Cowen.
Ratings data for NVO provided by MarketBeat
Stopped prediction by TD_Cowen for Novo Nordisk A/S ADR
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€47.20
19.08.25
19.08.25
€60.08
19.08.26
19.08.26
-11.55%
22:26
22:26
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€93.00
04.12.23
04.12.23
€106.28
04.12.24
04.12.24
11.83%
05.12.24
05.12.24

